DFX Intelligence
Private Credit Intelligence
The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Borrower
S••••••• P••••••••• I••
P•••••••••, Biotechnology & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $20.0M
sum of BDC pieces, a lower bound
Fair value
$20.4M
105c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Aug 31, 2030
no dated debt inside 24 months
On the tape since
Jun 30, 2026
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $20.0M | 105c | SOFR+675 bp | Aug 31, 2030 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| R••••• G••••• F•••••• C•••• | term loan first lien Investment Type Senior Secured Interest Rate SOFR+6.75% 10.50%floor 7.50%ETP Acquisition D | $4.0M | $4.1M 103c | SOFR+675 bp |
| R••••• G••••• F•••••• C•••• | term loan first lien Investment Type Senior Secured Interest Rate SOFR+6.75% 10.50%floor, 8.85%ETP Acquisition | $16.0M | $16.3M 105c | SOFR+675 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $20.0M | $20.4M | 105c | 0 |
What changed
- New borrower on a BDC scheduleJun 30, 2026
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- SINCERUS PHARMACEUTICALSderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- P•••••••••, Biotechnology & Life Sciencesreportedas one filer wrote it